Log in to save to my catalogue

Drug switching in axial spondyloarthritis patients in Germany – a social listening analysis

Drug switching in axial spondyloarthritis patients in Germany – a social listening analysis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_09d2bd4b1be04521aab00d1897b891b9

Drug switching in axial spondyloarthritis patients in Germany – a social listening analysis

About this item

Full title

Drug switching in axial spondyloarthritis patients in Germany – a social listening analysis

Publisher

London, England: SAGE Publications

Journal title

Therapeutic advances in musculoskeletal disease, 2023-01, Vol.15, p.1759720X231187189-1759720X231187189

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Background:
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease which primarily affects the axial skeleton resulting in chronic back pain and stiffness. According to the guideline, the first-line treatment includes non-steroidal anti-inflammatory drugs (NSAIDs), conventional synthetic disease-modifying antirheumatic drugs (csDMARDs...

Alternative Titles

Full title

Drug switching in axial spondyloarthritis patients in Germany – a social listening analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_09d2bd4b1be04521aab00d1897b891b9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_09d2bd4b1be04521aab00d1897b891b9

Other Identifiers

ISSN

1759-720X

E-ISSN

1759-7218

DOI

10.1177/1759720X231187189

How to access this item